MARCO Iansiti , KM Lakhani , HANNAH Mayer , KERRY Herman
Harvard Business School 9 -621
SV Shah , KM Lakhani , KN Patel , BA Patel
International Journal of Pharmaceutical research scholars, ISSN-2277-7873
KM Lakhani , SV Shah , KN Patel , BA Patel
Int J Pharma Res Sch 1 ( 2) 122 -35
MARCO IANSITI , KARIM R LAKHANI
Disruption 2020 14 -14
MARCO IANTISI , KARIM R LAKHANI
ANDREW KING , KARIM R LAKHANI
KARIM R Lakhani , JOHANN Füller , VOLKER Bilgram , GRETA Friar
Harvard Business School Case 614 -042
Kevin J. Boudreau , Karim R Lakhani
MIT Sloan Management Review 50 ( 4) 69 -76
Teppo Felin , Karim R Lakhani
Harvard Deusto business review ( 283) 64 -71
Kevin J Boudreau , Karim R Lakhani , Eva Guinan
MIT Sloan Management Review 54 ( 3) 45 -52
Aravind Subramanian , Karim R Lakhani , Karim R Lakhani , Rajiv Narayan
Bioinformatics
Teppo Felin , Karim R Lakhani , Michael L Tushman
Strategic Organization 15 ( 2) 119 -140
Karim R Lakhani , Kevin J Boudreau , Po-Ru Loh , Lars Backstrom
Nature Biotechnology 31 ( 2) 108 -111
Georg von Krogh , Sebastian Spaeth , Karim R Lakhani
Research Policy 32 ( 7) 1217 -1241
Jian Gao , Yian Yin , Kyle R Myers , Karim R Lakhani
Nature communications 12 ( 1) 6188
Misha Teplitskiy , Hao Peng , Andrea Blasco , Karim R Lakhani
Proceedings of the National Academy of Sciences 119 ( 47) e2118046119
Marco Iansiti , Karim R Lakhani
Smpte Journal
Robert Bock , Marco Iansiti , Karim R Lakhani
Harvard Business Review 31 ( 01) 2017
Kyle Myers , Karim R Lakhani , Dashun Wang
Available at SSRN 3712876
Leonard Boussioux , Jacqueline N Lane , Miaomiao Zhang , Vladimir Jacimovic
Harvard Business School